Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%. Here's why - Hindustan Times
close_game
close_game

Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%. Here's why

Reuters |
Mar 18, 2024 12:53 PM IST

Pfizer, which currently holds a 32% stake in Haleon, said last May it planned to cut its ownership in a "slow and methodical" manner within months.

Consumer healthcare giant Haleon said on Monday that Pfizer will sell about 630 million of its shares in the company, reducing the US drugmaker's stake to about 24%.

The Pfizer logo is seen at their UK commercial headquarters in Walton Oaks, Britain. (Reuters)
The Pfizer logo is seen at their UK commercial headquarters in Walton Oaks, Britain. (Reuters)

Pfizer, which currently holds a 32% stake in Haleon, said last May it planned to cut its ownership in a "slow and methodical" manner within months.

Unlock exclusive access to the latest news on India's general elections, only on the HT App. Download Now! Download Now!

Read more: Binny Bansal invests 200 crore more in startup Curefoods of ex-Flipkart executive: What we know

The offer price per share is expected to be announced on or around March 19, following the completion of a book-building process, Haleon said in a statement.

Haleon, which makes household brands such as Sensodyne toothpaste and Advil painkillers, was spun out of British drugmaker GSK in July 2022.

Since then, GSK has sold down its stake in the company, with the last sale in January bringing down its shareholding to 4.2%.

Tell us what your First Vote will stand for in a short video & get a chance to be featured on HT’s social media handles. Click here to know more!

Get Current Updates on India News, Elections 2024,, Election 2024 Date along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Saturday, May 18, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On